Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-449-4 | CAS number: 60-00-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
In rat as well as in human studies CaNa2EDTA and Na2EDTA is poorly absorbed from GI tract and the absorbed part rapidly excreted by urine, therefore one can rule out any danger of bioaccumulation. However, administration of EDTA salts results in an increased excretion of necessary ions like Zn, Mn or Ca.
Key value for chemical safety assessment
Additional information
In a study conducted by Foreman et al. (1953) 50 mg/kg bw of 14C labeled calcium salt of EDTA were administered to rats orally (gavage), intraperitoneally, intravenously or intramuscularly. After oral application calcium EDTA was poorly absorbed from gastrointestinal tract (2 - 18% within 24 h). Most of the administered dose was excreted by feces 80 - 95% and much less in urine (2 -18%). After parenteral application 95 - 98% (iv: 96.09%; ip: 98.67%; im: 95.35%) of the radioactivity was excreted in urine within 6 h after application, while less than 0.1% was exhaled as CO2. At this time point none of the tissues contained more than 0.5% of the radioactivity administered.
Two additional studies on the toxicokinetics of CaNa2EDTA after i.p. application are available. In one study rats got 10 injections of 300 - 436 mg/kg bw/day 14C-labeled CaNa2EDTA. 66 - 92% of the administered dose were recovered in urine while generally less than 5% were excreted in feces. 24 h after the last injection kidneys showed less than 0.1% of the radioactivity (Doolan, 1967). In the other study, 18 rats got a single i.p. application of 400 mg/kg bw 14[C]CaNa2EDTA. Within 22 h 80% of the radioactivity were excreted in urine, while the concentration in kidney homogenate was approximately 0.1 - 0.2% during this time period (Miller, 1986).
The effects of sc application of CaNa2EDTA on Zn, Cu and Mn metabolism were investigated in female dogs. CaNa2EDTA was applied with a dose of 280 mg/kg bw/ every 6 hours for 54 h. Urine was collected every 6 h and the Zn, Cu and Mn content analysed. CaNa2EDTA application increased the urinary excretion of Zn, Cu and Mn significantly (Ibim, 1992).
In addition, in poorly documented studies by Yang (1964) the toxicokinetics of Na2EDTA was analysed in rats. After gavage application of 47.5, 95 and 142.5 mg/kg bw the amount of EDTA ingested was proportional to the amount of urinary excretion with a peak excretion 4 h after application. After gavage administration of 400 mg/kg bw to weanling and adult rats roughly 90% of the dose were recovered in feces, while only 5.3 % (adults) - 8.6 % (weanlings) were recovered in urine within 48 h. It was therefore assumed that most of the orally applied EDTA is not absorbed. After a single gavage application of ca. 475 mg/kg bw to rats, the gastrointestinal tract was removed in intervals up to 32 h and the EDTA content analysed. All EDTA passed through the stomach within 12 h and 93% of the dose was recovered in the colon after 32 h, which demonstrated a poor absorption from GI tract. The EDTA contents of the small intestine and urine reached a maximum about 4 h after dosage. Urinary excretion over the period of 32 h cumulated to 6% of the dose. In an additional study Yang stated that of a dietary dose of 300, 600 and 3000 mg/kg bw 82%, 44% and 45% could be recovered in urine and feces. However, it is unclear were the residual percentage of Na2EDTA remained.
Foreman & Trujillo (1954) studied the toxicokinetics of 14C-CaNa2EDTA in young, healthy male volunteers. 4.2 mg test substance per person were applied i.v. or i.m. 50% of the dose was excreted in urine within 1 h (i.v.) or 2.5 h (i.m.). Within 24 h >98% of the dose was excreted in urine after both applications. The half-live blood clearance was 1 h 5 min (i.v.) or 1.5 h (i.m.) respectively. Additionally, Foreman & Trujillo administered 14C-CaNa2EDTA orally at a dose of 1.5 mg/person. CaNa2EDTA was poorly absorbed from gastrointestinal tract. Within 72 h 91% of the dose were excreted in feces and 4.2% in urine. No test substance could be detected in blood.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)